Table 3.
Levels of sPD-L1 and sPD-1 (pg/mL) in the plasma and PF of OC patients and in the plasma of healthy donors.
| Ovarian Cancer Patients | Healthy Donors | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Median | Minimum | Maximum | Median | Minimum | Maximum | Median | Minimum | Maximum | |
| Concentration of sPD-L1 (pg/mL) | Plasma (n = 34) | PF (n = 34) | Plasma (n = 20) | ||||||
| 63.37 * | 31.32 | 342.3 | 100.5 °°° | 22.91 | 231.8 | 60.40 | 38.58 | 667.2 | |
| Concentration of sPD-1 (pg/mL) | Plasma (n = 30) | PF (n = 27) | Plasma (n = 10) | ||||||
| 72.91 **** | 9.48 | 447.29 | 33.37 | 3.79 | 320.88 | 52.37 ° | 25.02 | 91.28 | |
The median value with the following marks indicate statistically significant differences between the median value of the sPD-L1/sPD-1 concentration in the plasma and PF of the OC patients (* p < 0.05, **** p < 0.0001) and in the plasma of the OC patients and healthy blood donors (° p < 0.05, °°° p < 0.001).